SCHEMBL7093264

SCHEMBL7093264

CSc1ncnc(NCCl)n1

nearest known ligand 0.41

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 1/20 0.31
▸ KMT2A Q03164 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9292846 0.83 TSHR (0.41) MEN1KMT2A
SCHEMBL6256220 0.80 CYP1A2 (0.35) MEN1KMT2A
SCHEMBL18757583 0.79 CXCR4 (0.38) —
SCHEMBL11361526 0.79 MEN1 (0.37) MEN1KMT2A
SCHEMBL11684387 0.77 CYP1A2 (0.46) —
SCHEMBL6448611 0.75 — —
SCHEMBL11460652 0.74 KCNH3 (0.43) KMT2A
SCHEMBL6511999 0.72 KMT2A (0.38) MEN1KMT2A
SCHEMBL9021224 0.72 SMN1; SMN2 (0.43) MEN1KMT2A
SCHEMBL9526292 0.72 TSHR (0.40) MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1341773-A2 SUBSTITUTED 1,3,5-TRIAZINES AND PYRIMIDINES AS ABCA-1 ELEVATING COMPOUNDS AGAINST CORONARY ARTERY DISEASE OR ATHEROSCLEROSIS CV THERAPEUTICS, INC. (US) 2003-09-10 — — EP disclosed
WO-2002046172-A2 SUBSTITUTED 1, 3, 5-TRIAZINES AND PYRIMIDINES AS ABCA-1 ELEVATING COMPOUNDS AGAINST CORONARY ARTERY DISEASE OR ATHEROSCLEROSIS CV THERAPEUTICS, INC. (US) 2002-06-13 — — WO disclosed
Send feedback